Skip to content
DraconiticResearch
Search Sources API
206,698 studies31 sourcesUpdated 54 min ago

Oncology

5,185 studies511 in 7 days2,486 in 30 days

Filters
Type
Date
Clear

Latest

5,185 studies

  1. Regio-specific glycan expression within the mammalian brain and tumors
    Ea Kristine Clarisse Tulin, Maxence Noel, Lauren E. Pepi +5
    iSciencePeer-reviewedCC BY-NC 4.0Full textOncologyCell PressCrossrefEurope PMCPMC
  2. A single arm phase II trial of chidamide plus cisplatin in advanced adenoid cystic carcinoma
    Yizhen Liu, Guang-Liang Chen, Kai Xue +9
    iSciencePeer-reviewedCC BY-NC-ND 4.0Full textOncologyCell PressCrossrefEurope PMCPMC
  3. A biomarker analysis of plasma RIME and PD-L1 for stratifying first-line immunochemotherapy outcomes in advanced ESCC
    Jia Liu, Rui-Qi Ren, Ye He +6
    iSciencePeer-reviewedCC BY 4.0Full textOncologyCell PressCrossrefEurope PMCPMC
  4. Periodontitis as a potential contributor to lung cancer: Epidemiological evidence, proposed mechanisms, and clinical implications
    Hanchi Dong, Hua Xin
    iSciencePeer-reviewedCC BY-NC-ND 4.0Full textOncologyCell PressCrossrefEurope PMCEurope PMC+1
  5. Small-molecule inhibitors and checkpoint inhibitors in KRAS G12C NSCLC: balancing efficacy and toxicity.
    Emma D A Wagener, Anneloes L Noordhof, Wouter H van Geffen
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  6. SNORD42A serves as an oncogenic biomarker in non-small cell lung cancer.
    Chunhong Cui, Yan Wang, Jing Xia +4
    Journal of thoracic diseasePeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  7. Trastuzumab rezetecan (SHR-A1811) for the treatment of HER2-positive advanced colorectal cancer: a report of two cases.
    Dongyan Chen, Yujun Zheng
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  8. Lactate dehydrogenase to albumin ratio as a potential indicator of pathological response and prognosis in non-small cell lung cancer patients undergoing neoadjuvant chemoimmunotherapy followed by surgery.
    Bohua Wei, Kejian Shi, Kun Qian +3
    Journal of thoracic diseasePeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  9. Association and incremental predictive performance of preoperative nutritional and inflammatory indices for postoperative ICU admission after hepatobiliary and pancreatic tumor surgery
    Longyun Ou, Haozhu Wang
    Frontiers in NutritionPeer-reviewedCC BY 4.0Full textOncologyPMC
  10. Matrix-state switching in osteosarcoma under therapeutic pressure: integrin rewiring, residual disease, and pulmonary niche adaptation
    Yang Gu, Yunqiang Zhuang, Wei Zhang
    Frontiers in Cell and Developmental BiologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  11. DeepOSSA: a deep learning framework for personalized survival prediction in osteosarcoma patients
    Zongdong Zhu, Xiaowei Sha, Chengliang Yin +2
    Frontiers in Cell and Developmental BiologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  12. Identification of SLC7A5 and transferrin as key ferroptosis modulators in triple-negative breast cancer
    Ruidi Liu, Xiao Cui, Bingyu Guo +4
    Oncology LettersPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  13. Treg and immune proliferative programs characterize anti-PD-1-responsive endometrial cancer: an integrative single-cell, spatial transcriptomic, and TCGA-UCEC reanalysis
    Yuan Zheng, Jingsheng Chen, Qing Wang +1
    Frontiers in GeneticsPeer-reviewedCC BY 4.0Full textOncologyPMC
  14. Lifestyle-induced regulatory T cell fragility primes adverse events after immune checkpoint blockade
    Dipyaman Patra, Katelyn Wolfgang, Chenxian Ye +15
    CellPeer-reviewedLicence not statedFull textOncologyPMC
  15. An epithelioid vascular tumour involving a thigh vein mimicking a saphenous nerve lesion: a case report
    Gopi Gopalapillai, Benedict Kakala, Jason Miller
    Journal of Surgical Case ReportsPeer-reviewedCC BY 4.0Full textOncologyPMC
  16. Immune remodeling in inflammatory bowel disease-associated colorectal cancer: Mechanisms and immunotherapeutic implications (Review)
    Tao Zhang, Zhetan Ren, Ling Wang +6
    International Journal of Molecular MedicinePeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  17. Glucose-Dependent Cytotoxic Responses in Triple-Negative Breast Cancer: Experimental and Transcriptomic Evidence of Metabolic Context and p38 MAPK-Associated Modulation
    Ishrat Rahman, Hanan Henidi, Aisha Alshibli +8
    Breast Cancer : Targets and TherapyPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  18. Latent Transition Analysis of Symptom Burden Before and After Pulmonary Rehabilitation in Postoperative Lung Cancer Patients.
    Ying Wu, Qun Yang, Jinguo Wang +2
    Cancer management and researchPeer-reviewedCC BY-NCFull textOncologyEurope PMCPMC
  19. 4Kscore as a Pre-MRI Reflex Test for Men with PSA 1.80–2.99 ng/ml in the Göteborg-2 Prostate Cancer Screening Trial
    Fredrik Möller, Andreas Josefsson, Marianne Månsson +6
    European Urology Open SciencePeer-reviewedCC BYFull textOncologyDOAJEurope PMCEurope PMCPMC
  20. Loss of Ferroptosis-suppressors Accelerates Breast Cancer Recurrence by Promoting Dormancy Exit
    E. K. Shea, M. Lawrence-Paul, A. Sreekumar +7
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  21. Targeting IGF2BP1 Creates a Mitotic Vulnerability in Colorectal Carcinoma
    B. Griesler, S. Hagemann, R. Winkler +15
    bioRxivPreprintCC BYFull textOncologybioRxiv
  22. Affinity Maturation Enables Dual Targeting of Cancer-Associated MUC1-Tn/STn and Drives Potent Tumor Control
    J. YE, X. Zhu, H. Lu +12
    bioRxivPreprintAll rights reservedFull textOncologybioRxivPMC
  23. From Splicing to Survival: Understanding the Molecular Basis of Prognostic Differences in advanced Small Intestine Neuroendocrine Tumors
    V. Garcia-Vioque, A. Garcia-Alvarez, M. T. Moreno-Montilla +14
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  24. Effects of panitumumab on the proteome of treated EGFRvIII glioblastoma cells and on their extracellular vesicles
    A. Gateau, B. Moeglen-Paget, S. Durand +4
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  25. A polysynaptic hypothalamuspelvic-ganglion circuit regulates prostate tumor growth via WNT3A
    W. Ran, P. Wu, Z. Qiao +11
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv